Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 206

Sort by

Sort Order Select

Journal Articles

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Sonja Seliger, Verena Geirhos, Torsten Haferlach, MD, Wolfgang Kern, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Anna Stengel, PhD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1774.

https://doi.org/10.1182/blood-2019-124704

Published: 2019

Journal Articles

The Impact of a Reflex Testing Strategy for High Risk Chromosome 14 Abnormalities on FISH Laboratory Costs in Multiple Myeloma

Marta Isabel Pereira, MD, Gilberto Marques, MD, Joana Lima, Artur Paiva, Maria Leticia Ribeiro, MD PhD, Fernando Rodrigues, MD

Blood (2019) 134 (Supplement_1): 3420.

https://doi.org/10.1182/blood-2019-132207

Published: 2019

Journal Articles

TP53 Status As Well As Cytogenetic Complexity Significantly Impact on Prognosis in Myelodysplastic Syndromes with Complex (≥3 anomalies) Aberrant Karyotypes

Blood (2019) 134 (Supplement_1): 3007.

https://doi.org/10.1182/blood-2019-126671

Published: 2019

Journal Articles

Protein Arginine Methyltransferase 1 (PRMT1) Dampens Self-Renewal and Promotes Differentiation of Hematopoietic Stem Cells in Mouse Models

Hairui Su, PhD, Szu-Mam Liu, PhD, Chiao-Wang Sun, PhD, Mark T. Bedford, PhD, Xinyang Zhao, PhD

Blood (2019) 134 (Supplement_1): 2460.

https://doi.org/10.1182/blood-2019-127226

Published: 2019

Journal Articles

Features of an Unusual AML with t(4;12)/ Pdgra-ETV6 As the Sole Cytogenetic Abnormality Associated with Myelodysplastic Changes: A Case Report and Literature Review

Jitakshi De, MD, L. Jeffrey Medeiros, MD

Blood (2019) 134 (Supplement_1): 5162.

https://doi.org/10.1182/blood-2019-129035

Published: 2019

Journal Articles

Recreation of t(7;12)(q36;p13) in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Generates a Useful Model for Studying Acute Myeloid Leukemia

Tina Nilsson, MSc, BSc, Ahmed Waraky, PhD MSc, BSc, Anders Östlund, MSc, BSc, Laleh Arabanian, PhD, Julia Asp, PhD, Linda Fogelstrand, Lars Palmqvist, MD PhD

Blood (2019) 134 (Supplement_1): 2736.

https://doi.org/10.1182/blood-2019-123004

Published: 2019

Journal Articles

C/Ebpg (CCAAT/Enhancer Binding Protein Gamma) Balances Cytotoxic and Secretory Potential of Natural Killer Cells

Izabela Aparecida Lopes, MSc, Miroslava Kardosova, MSc, Thiago Mantello Bianco, MSc, Adriana Queiroz Arantes, MD, Cleide Araújo Silva, MSc, Priscila Santos Scheucher, PhD, Daniel G. Tenen, MD, Sanghoon Lee, PhD, Eduardo Magalhães Rego, MD PhD, Robert S. Welner, PhD, Meritxell Alberich-Jorda, Lorena Lobo Figueiredo-Pontes, MD PhD

Blood (2018) 132 (Supplement 1): 3721.

https://doi.org/10.1182/blood-2018-99-119389

Published: 2018

Journal Articles

Understanding the Role of Hyperdiploidy in Burkitt Lymphoma of Childhood: Biological and Clinical Correlates

Georgia Avgerinou, MD, Stefanos Papadhimitriou, Kalliopi Stefanaki, MD PhD, Antonis Kattamis, Katerina Katsibardi, MD PhD, Vassilios Kostopoulos, Dimitrios Pavlidis, Sophia Polychronopoulou, MD PhD

Blood (2018) 132 (Supplement 1): 5296.

https://doi.org/10.1182/blood-2018-99-113091

Published: 2018

Journal Articles

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Juan Du, MD PhD, Jing Lu, Wanting Qiang, Lu Li, Jin Liu, Hua Jiang, MD, Ziliang Qian, PhD, Baoan Chen, MD PhD, Weijun Fu, MD PhD

Blood (2018) 132 (Supplement 1): 5603.

https://doi.org/10.1182/blood-2018-99-116260

Published: 2018

Journal Articles

Outcomes of Myeloma Patients with t(11;14) Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy

Jonathan L Kaufman, MD, Nisha Joseph, MD, Vikas A. Gupta, MD PhD, Charise Gleason, ANP, Craig C Hofmeister, MD MPH, Leonard Heffner, MD, Madhav V Dhodapkar, MD, Sagar Lonial, MD, Lawrence H. Boise, PhD, Ajay K Nooka, MD MPH

Blood (2018) 132 (Supplement 1): 3282.

https://doi.org/10.1182/blood-2018-99-119051

Published: 2018

Journal Articles

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

John G. Quigley, MD, Basharath Khan, MD, Nandini Kalakota, MD, Nathan Aardsma, DO, Nadim Mahmud, MBBS, PhD

Blood (2017) 130 (Supplement 1): 5259.

https://doi.org/10.1182/blood.V130.Suppl_1.5259.5259

Published: 2017

Journal Articles

A Single Cleavage Reaction in the Proteolytic Activation of Factor V to the Cofactor Is Rate-Limiting in a Step That Is Selectively Dependent on Anion Binding Exosite 2 of Thrombin

Harlan N Bradford, BA, Sriram Krishnaswamy, PhD

Blood (2017) 130 (Supplement 1): 3649.

https://doi.org/10.1182/blood.V130.Suppl_1.3649.3649

Published: 2017

Journal Articles

High-Resolution Architecture and Partner Genes of MYC Rearrangements in Lymphoma with DLBCL Morphology

Blood (2017) 130 (Supplement 1): 4007.

https://doi.org/10.1182/blood.V130.Suppl_1.4007.4007

Published: 2017

Journal Articles

Superiority of Obinutuzumab over Rituximab in a New Molecular Follicular Lymphoma-like Subgroup of DLBCL: Results from an Exploratory Analysis of the Phase 3 GOYA Trial

Mikkel Z. Oestergaard, Christopher Bolen, Federico Mattiello, Maurizio Martelli, Laurie H. Sehn, MDMPH, Marek Trněný, MD PhD, Alexandar Tzankov, Umberto Vitolo, MD, Tina Nielsen, Rodica Morariu-Zamfir, Günter Fingerle-Rowson, Georg Lenz

Blood (2017) 130 (Supplement 1): 1543.

https://doi.org/10.1182/blood.V130.Suppl_1.1543.1543

Published: 2017

Journal Articles

Translocations and Jumping Rearrangements at 8q24 Result in over-Expression of MYC and are Key Drivers of Disease Progression

Erming Tian, PhD, Jeffery Sawyer, Owen W Stephens, Ruslana Tytarenko, Sharmilan Thanendrarajan, MD, Carolina Schinke, MD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Faith E Davies, MD, Brian A Walker, PhD, Gareth J Morgan, MD PhD

Blood (2016) 128 (22): 115.

https://doi.org/10.1182/blood.V128.22.115.115

Published: 2016

Journal Articles

Eltrombopag (ELT) Reverses Iron Mediated Suppression of Insulin Secretion in Pancreatic Cells By Chelating Iron and Decreasing ROS

Evangelia Vlachodimitropoulou Koumoutsea, MBBS, Pimpisid Koonyosying, BSc, John B. Porter, BA MB BChir MRCP(Path) FRCP(Path) MD, Nichola Cooper, MA, MD MRCP, FRCPath, Bethan Psaila, Martha Sola-Visner, MD

Blood (2016) 128 (22): 1278.

https://doi.org/10.1182/blood.V128.22.1278.1278

Published: 2016

Journal Articles

Concurrent Amplification of MYC and 1q21 in Multiple Myeloma: Focal and Segmental Jumping Translocations of MYC

Jeffery Sawyer, Erming Tian, PhD, Brian A Walker, PhD, Niels Weinhold, PhD, Charles Swanson, Janet L Lukacs, Regina Binz, Gael Sammartino, Sharmilan Thanendrarajan, MD, Carolina Schinke, MD, Maurizio Zangari, MD, Faith E Davies, MD, Frits van Rhee, MD PhD, Gareth J Morgan, MD PhD

Blood (2016) 128 (22): 3266.

https://doi.org/10.1182/blood.V128.22.3266.3266

Published: 2016

Journal Articles

Predicting Poor Overall Survival in Patients with Newly Diagnosed Multiple Myeloma and Standard-Risk Cytogenetics Treated with Novel Agents

Moritz Binder, MD MPH, S. Vincent Rajkumar, MD, Rhett P. Ketterling, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, Morie A. Gertz, MD, Francis K Buadi, MD, Suzanne R. Hayman, MD, Yi L. Hwa, DNP, Steven R. Zeldenrust, MD PhD, John A Lust, MD PhD, Stephen J. Russell, MD PhD, Nelson Leung, MD, Prashant Kapoor, MD, Ronald S. Go, MD, Wilson I Gonsalves, MD, Robert A. Kyle, MD, Shaji K. Kumar, MD

Blood (2016) 128 (22): 3255.

https://doi.org/10.1182/blood.V128.22.3255.3255

Published: 2016

Journal Articles

Microrna 221 Expression By Leukocytes Strongly Correlates with the Clinical Severity of Sickle Cell Disease

Iheanyi Okpala, FRCPath. FWACP., Ndubuisi Uwaezuoke, FMCPaed, Ifeoma Emodi, FMCPaed, Anthony Ikefuna, FMCPaed, Tagbo Oguonu, FMCPaed

Blood (2016) 128 (22): 2485.

https://doi.org/10.1182/blood.V128.22.2485.2485

Published: 2016

Journal Articles

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Paolo Bernasconi, MD, Irene Dambruoso, Marina Boni, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Antonella Orlando, Ilaria Casetti, MD, Chiara Elena, MD, Elisa Rumi, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 5493.

https://doi.org/10.1182/blood.V128.22.5493.5493

Published: 2016

NARROW

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

The Impact of a Reflex Testing Strategy for High Risk Chromosome 14 Abnormalities on FISH Laboratory Costs in Multiple Myeloma

TP53 Status As Well As Cytogenetic Complexity Significantly Impact on Prognosis in Myelodysplastic Syndromes with Complex (≥3 anomalies) Aberrant Karyotypes

Protein Arginine Methyltransferase 1 (PRMT1) Dampens Self-Renewal and Promotes Differentiation of Hematopoietic Stem Cells in Mouse Models

Features of an Unusual AML with t(4;12)/ Pdgra-ETV6 As the Sole Cytogenetic Abnormality Associated with Myelodysplastic Changes: A Case Report and Literature Review

Recreation of t(7;12)(q36;p13) in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Generates a Useful Model for Studying Acute Myeloid Leukemia

C/Ebpg (CCAAT/Enhancer Binding Protein Gamma) Balances Cytotoxic and Secretory Potential of Natural Killer Cells

Understanding the Role of Hyperdiploidy in Burkitt Lymphoma of Childhood: Biological and Clinical Correlates

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Outcomes of Myeloma Patients with t(11;14) Receiving Lenalidomide, Bortezomib, and Dexamethasone (RVD) Induction Therapy

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

A Single Cleavage Reaction in the Proteolytic Activation of Factor V to the Cofactor Is Rate-Limiting in a Step That Is Selectively Dependent on Anion Binding Exosite 2 of Thrombin

High-Resolution Architecture and Partner Genes of MYC Rearrangements in Lymphoma with DLBCL Morphology

Superiority of Obinutuzumab over Rituximab in a New Molecular Follicular Lymphoma-like Subgroup of DLBCL: Results from an Exploratory Analysis of the Phase 3 GOYA Trial

Translocations and Jumping Rearrangements at 8q24 Result in over-Expression of MYC and are Key Drivers of Disease Progression

Eltrombopag (ELT) Reverses Iron Mediated Suppression of Insulin Secretion in Pancreatic Cells By Chelating Iron and Decreasing ROS

Concurrent Amplification of MYC and 1q21 in Multiple Myeloma: Focal and Segmental Jumping Translocations of MYC

Predicting Poor Overall Survival in Patients with Newly Diagnosed Multiple Myeloma and Standard-Risk Cytogenetics Treated with Novel Agents

Microrna 221 Expression By Leukocytes Strongly Correlates with the Clinical Severity of Sickle Cell Disease

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only